Home   |  Kontaktandmed   |  Asukohad
Safe Infusion Therapy (ET)


AFS Cytostatics and other medications with permanent toxic effects [translation] Swedish Work Environment Agency 2005: 5

ASTM. D6978-05: Standard Practice for Assessment of Resistance of Medical Gloves to Permeation by Chemotherapy Drugs, American Society for Testing and Materials 2005

Crauste-Manciet S, Sessink PMJ, Ferrari S, Jomier JY, Brossard D. Environmental Contamination with Cytotoxic Drugs in Healthcare Using Positive Air Pressure Isolators. Ann Occup Hyg 2005; 49(7): 619–628

Falck K, Gröhn P, Sorsa M, Vainio H, Heinonen E, Holsti LR. Mutagenicity in urine of nurses handling cytostatic drugs. Lancet 1979; 1(8128): 1250–1251

Flintoff JP. Thalidomide: the battle for compensation goes on. The Sunday Times. March 23, 2008

Fransman W, Vermeulen R, Kromhout H. Occupational dermal exposure to cyclophosphamide in Dutch hospitals: a pi lot study. Ann Occup Hyg 2004; 48(3): 237–244

Gielen K, Goossens A. Occupational allergic contact dermatitis from drugs in healthcare workers. Contact Dermatitis 2001; 45: 273–279

Health Counsel of the Neatherlands. Risk assessment of carcinogenic chemicals in the Neatherlands. Regul Toxicol Pharmacol 1994; 19: 14-30

Hemminki K, Kyyrönen P, Lindbohm M-L. Spontaneous abortions and malformation in the offspring of nurses exposed to anaesthetic gases, cytostatic drugs, and other potential hazards in hospitals, based on registered information of outcome. J Epidemiol Community Health 1985; 39: 141-147

Horner MJ, Ries LAG, Krapcho M, et al (eds). SEER Cancer Statistics Review, 1975-2006, National Cancer Institute. Bethesda, Md, based on November 2008 SEER data submission, posted to the SEER website, 2009. Table I-21, US Prevalence Counts, Invasive Cancers Only, January 1, 2006, Using Different Tumor Inclusion Criteria. Accessed at http://seer.cancer.gov/csr/1975_2006/results_single/sect_01_table.21_2pgs.pdf on September 3, 2009

IARC Monographs on the Evaluation of Carcinogenic Risks to Humans - Overall Evaluations of Carcinogenicity: An Updating of IARC Monographs 1987. Supplement 7; Volumes 1-42

IGBCE. Manteltarifvertrag 2000

Kromhout H, Hoek F, Uitterhoeve R, Huijbers R, Overmars RF, Anzion R, Vermeulen R. Postulating a dermal pathway for exposure to antineoplastic drugs among hospital workers. Applying a conceptual model to the results of three workplace sur veys. Ann Occup Hyg 2000; 44(7): 551–560

Larson RR, Khazaeli MB,»Dillon HK. A New Monitoring Method Using Solid Sorbent Media for Evaluation of Airborne Cyclophosphamide and Other Antineoplastic Agents. Appl Occup Environ Hyg 2003; 18(2): 120-131

Macmillan cancer support website. A guide to benefits and financial help for people affected by cancer.

Mälkönen T, Jolanki R, Alanko K, Luukkonen R, Aalto-Korte K, Lauerma A, Susitaival P. A 6-month follow-up study of 1048 patients diagnosed with an occupational skin disease. Contact Dermatitis 2009; 61(5): 261-8

Mason HJ, Morton J, Gar_ tt SJ, Iqbal S, Jones K. Cytotoxic drug contami nation on the outside of vials delivered to a hospital pharmacy. Ann Occup Hyg 2003; 47(8): 681–685

McDiarmid MA, Egan T. Acute occupational exposure to antineoplastic agents. J Occup Med 1988; 30(12): 984–987

National Cancer Institute website (USA).

Neal AdW, Wadden RA, Chiou WL. Exposure of hospital workers to airborne antineoplastic agents. Am J Hosp Pharm 1983; 40(4): 597-601

Nguyen TV, Theiss JC, Matney TS. Exposure of pharmacy personnel to muta genic antineoplastic drugs. Cancer Res 1982; 42: 4792–4796

NHS Careers website. http://www.nhscareers.nhs.uk/

NIOSH Alert: Preventing occupational exposures to antineoplastic and other hazardous drugs in health care settings. U.S. Department of Health and Human Services, Public Health Service, Centers form Disease Control and Prevention, National Institute for Occupational Safety and Health, DHHS (NIOSH) 2004. Publication No. 2004-165

Paclitaxel SmPC. BMS 2010

QuapoS 3 Quality Standard for the Oncology Pharmacy Service with Commentary. Institute for Applied Healthcare Sciences (IFAHS e.V.) for the German Society of Oncology Pharmacy (DGOP e.V.). 2003

Rogers B, Emmett EA. Handling anti-neoplastic agents: urine mutagenicity in nurses. J Nurs Scholarsh 1987; 19: 108–113

Sarto F, Trevisan A, Tomanin R, Canova A, Fiorentino M. Chromosomal Aberrations, Sister Chromatid Exchanges, and Urinary Thioethers in Nurses Handling Antineoplastic Drugs. Am J Ind Med 1990; 18: 689495

Schmaus G, Schierl R, Funck S. Monitoring surface contamination by anti-neoplastic drugs using gas chromatography-mass spectrometry and voltammetry. Am J Health Syst Pharm 2002; 59: 956–961

Selevan SG, Lindbohm M-L, Hornung RW, Hemminki K. A study of occupational exposure to antineoplastic drugs and fetal loss in nurses. N Engl J Med 1985; 313(19): 1173–1178

Sessink PJM, Van De Kerkhof MCA, Anzion RBM, Noordhoek J, Bos RP. Environmental contamination and assessment of exposure to antineoplastic agents by determination of cyclophosphamide in urine of exposed pharmacy technicians: is skin absorption an important exposure route? Arch Environ Health 1994; 49(3): 165–169

Sessink PJM, Kroese ED, van Kranen HJ, Bos RP. Cancer risk assessment for health care workers occupationally exposed to cyclophosphamide. Int Arch Occup Environ Health 1995; 67: 317-323

Skov T, Maarup B, Olsen J, Rørth M, Winthereik H, Lynge E. Leukaemia and reproductive outcome among nurses handling antineoplastic drugs. Br J Ind Med 1992; 49: 855–861

Sotaniemi EA, Sutinen S, Arranto AJ, Sutinen S, Sotaniemi KA, Lehtola J, Pelkonen RO. Liver Damage in Nurses Handling Cytostatic Agents. Acta Med Scand 1983; 214: 181-9

Stücker I, Caillard J-F, Collin R, Gout M, Poyen D, Hémon D. Risk of spontaneous abortion among nurses handling antineoplastic drugs. Scand J Work Environ Health 1990; 16: 102–107

Ündeger Ü, Baþaran N, Kars A, Güç D. Assessment of DNA damage in nurses handling antineoplastic drugs by the alkaline COMET assay. Mutat Res 1999; 439: 277–285

Valanis BG, Vollmer WM, Labuhn KT, Glass AG. Ägedad sümptomid, mis seonduvad antineoplastiliste ravimite käsitsemisega medõdede seas. Cancer Nurs 1993a; 16(4): 288–295

Valanis BG, Vollmer WM, Labuhn KT, Glass AG. Association of antineoplastic drug handling with acute adverse effects in pharmacy personnel. Am J Hosp Pharm 1993b; 50: 455–462

Valanis B, Vollmer WM, Steele P. Occupational exposure to antineoplastic agents: self-reported miscarriages and stillbirths among nurses and pharmacists. J Occup Environ Med 1999; 41(8): 632–638


Not all products are registered and approved for sale in all countries or regions. Indications of use may also vary by country and region. Product images are for reference only. Please contact your country representative for product availability and information.